T-cell dysregulation caused by chronic antigenic stress: The role of CMV in immunosenescence?

Aging Clinical and Experimental Research

Volumn 18, Issue 2, 2006, Pages 171-173

  Pawelec, Graham ^a   Gouttefangeas, Cécile ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Institute for Cell Biology   (Germany)

Author keywords

Clonal expansions; CMV; Immunosenescence; T cells

Indexed keywords

T LYMPHOCYTE ANTIGEN;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; ELDERLY CARE; HERPES VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; LONGITUDINAL STUDY; MORTALITY; PREDICTION; RISK ASSESSMENT; SENESCENCE; T LYMPHOCYTE; VIRUS REACTIVATION;

CYTOMEGALOVIRUS; HERPESVIRIDAE;

EID: 33744807190     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03327436     Document Type: Article

References (16)

1. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG. Age-related changes in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000; 121: 187-201.
2. Looney RJ, Falsey A, Campbell D, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999; 90: 213-9.
3. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994; 179: 609-18.
4. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-92.
5. Wills MR, Okecha G, Weekes MP, Gandhi MK, Sissons PJ, Carmichael AJ. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol 2002; 168: 5455-64.
6. Pittet MJ, Zippelius A, Speiser DE, et al. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J Immunol 2001; 166: 7634-40.
7. Trzonkowski P, Mysliwska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 2003; 21: 3826-36.
8. Sinicco A, Raiteri R, Sciandra M, Dassio G, Bechis G, Maiello A. The influence of cytomegalovirus on the natural history of HIV infection: evidence of rapid course of HIV infection in HIV-positive patients infected with cytomegalovirus. Scand J Infect Dis 1997; 29: 543-9.
9. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004; 117: 265-77.
10. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8+ T cells accumulate in the elderly. Exp Gerontol 2004; 39: 607-13.
11. Kern F, Bunde T, Faulhaber N, et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002; 185: 1709-16.
12. Li Pira G, Bottone L, Ivaldi F, et al. Recognition of CMV pp65 protein antigen by human CD 4 T-cell lines induced with an immunodominant peptide pool. Hum Immunol 2004; 65: 537-43.
13. Sester M, Sester U, Gartner B, et al. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol 2002; 76: 3748-55.
14. thor Straten P, Becker JC, Guldberg P, Zeuthen J. In situ T cells in melanoma. Cancer Immunol Immunother 1999; 48: 386-9.
15. Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999; 5: 677-85.
16. Pawelec G. Tumour escape: antitumour effectors too much of a good thing? Cancer Immunol Immunother 2004; 53: 262-74.